Liver Cancer Prevention
Liver Cancer Prevention
Liver cancer is one of the few major cancers with a genuine prevention story: a vaccine, a blood test, an antiviral tablet and a scan every six months between them remove or intercept most of the risk.
Vaccination against hepatitis B
The hepatitis B vaccine is the single most effective liver cancer prevention measure available, because it prevents the infection that causes the majority of cases. Its impact can be measured: in regions that introduced universal infant vaccination, the incidence of liver cancer in children and young adults fell sharply within a couple of decades — one of the clearest demonstrations in cancer prevention that removing a cause prevents the disease.
Three doses give protection to the great majority of people, and the series is part of routine childhood immunisation in China and many other countries. Adults who were never vaccinated should ask about it, particularly if they have a family member with hepatitis B, work in healthcare, travel or work in settings with higher exposure, or have a condition or treatment affecting immunity. Being vaccinated as an adult is not too late: the point is to prevent infection before it happens, and hepatitis B can be acquired at any age.
Know your hepatitis status, and treat it
One blood test covers both hepatitis B and hepatitis C. If you carry either virus, you belong to a group for whom surveillance is worthwhile, and effective treatment exists for both — which turns an incidental finding into an actionable one.
Hepatitis B can be suppressed
Antiviral treatment lowers the amount of virus in the body and reduces the inflammation that drives liver damage. It substantially reduces the risk of liver cancer, though it does not eliminate it — which is why surveillance continues during treatment. Treatment is generally lifelong for those who need it, and monitoring includes viral load and liver function at set intervals.
Hepatitis C can be cured
Direct-acting antiviral tablets clear the infection in the great majority of people treated, over a course of weeks. If cirrhosis is already present when the virus is cleared, cancer risk remains and surveillance continues; if it is not, the future risk falls substantially. Either way, cure is worth having.
Who needs surveillance, and how often
Surveillance is not a general check-up. It is offered to groups whose risk of liver cancer is high enough that regular scanning has been shown to find tumours at a treatable stage. The standard test is a liver ultrasound together with an AFP blood test, repeated every six months.
| Cirrhosis from any cause | Surveillance every six months, indefinitely — regardless of whether the underlying cause is treated or cured |
|---|---|
| Chronic hepatitis B | Surveillance every six months, including in people without cirrhosis — the virus can cause cancer before scarring appears |
| Chronic hepatitis C | Surveillance every six months where there is advanced fibrosis or cirrhosis; after cure, continue if cirrhosis is present |
| Advanced fatty liver disease | Surveillance where fibrosis assessment shows significant scarring; not generally required for simple fat accumulation |
| Rare inherited liver conditions | Surveillance where there is cirrhosis or significant fibrosis — for example haemochromatosis or alpha-1 antitrypsin deficiency |
Criteria differ slightly between international and national guidelines, and the final decision is made with your physician, who can take other conditions into account.
What surveillance can and cannot do
It reliably finds tumours while they are small enough for removal or ablation in the great majority of cases, and it is why people in surveillance programmes are diagnosed earlier than people who wait for symptoms. It is not perfect: a scarred liver is harder to image, and small lesions can be missed — which is why a technically difficult ultrasound should be followed by contrast imaging rather than by reassurance alone.
Keeping the interval
Six months is chosen so that a tumour cannot grow from treatable to untreatable between scans. The commonest reason surveillance fails is not a missed lesion but a missed appointment: write the next date down, and know who is responsible for booking it. If your AFP result rises without a clear explanation, bring the scan forward rather than waiting for the next interval.
Protecting the liver from alcohol, aflatoxin and medicines
Alcohol
Risk rises with cumulative intake and multiplies the risk carried by viral hepatitis. For anyone with established cirrhosis, the advice is to stop rather than to moderate; for everyone else, less is better, and none is best.
Aflatoxin in food
A mould toxin that forms on poorly stored maize, groundnuts, rice and nuts. Store staples dry and cool, discard anything mouldy, discoloured or bitter-tasting, and be careful with traditional home-stored grains. The risk is highest where hepatitis B is also present.
Medicines and supplements
Herbal and dietary supplements are a recognised cause of liver injury, and "natural" does not mean harmless. Tell your doctor about everything you take, including products bought online, and avoid combining alcohol with paracetamol at the upper end of the dose range.
Metabolic health is cancer prevention too
Because fatty liver disease has become one of the fastest-growing routes to liver cancer, the ordinary measures that improve metabolic health now count as cancer prevention rather than as general advice. Weight reduction of the order of several per cent of body weight improves liver inflammation, and greater reduction can improve fibrosis; regular physical activity helps independently of weight; and control of blood sugar and blood lipids reduces progression of the underlying liver disease.
Type 2 diabetes deserves specific mention. It is both a risk factor for liver cancer and a condition whose treatment can affect the liver, so anyone with diabetes and a history of liver disease should have both managed together rather than in separate clinics. If your fibrosis stage has never been assessed, that assessment is the single most useful step — it determines whether you need surveillance rather than lifestyle advice alone.
Diet, supplements and the honest limits
A large market exists for products sold as liver protection. The evidence does not support the claims, and in a damaged liver some products carry risk.
No supplement prevents liver cancer
No vitamin, mineral or herbal product has been shown to prevent liver cancer. Anyone selling a "liver detox" is selling a story, not a treatment that has been tested.
Some are actively harmful
High-dose vitamin A and iron supplements can injure the liver, particularly where there is already fibrosis, and several herbal preparations are implicated in drug-induced liver injury. Discuss every product with your physician.
Coffee is the modest exception
Regular coffee drinking is associated with lower rates of liver fibrosis progression in observational studies. The association is consistent but modest, and it is not a substitute for treatment or surveillance.
A four-step personal prevention plan
If you have never had the hepatitis B vaccine series, ask for it. If you may have been exposed, test for hepatitis B and C — the result is what makes the rest of this page applicable to you.
Antiviral treatment for hepatitis B, cure for hepatitis C, and metabolic management for fatty liver disease. Each of these reduces the ongoing injury that leads to cancer.
Six-monthly ultrasound with AFP testing for cirrhosis, chronic hepatitis B, or chronic hepatitis C with advanced fibrosis. Write the next date down and keep it.
Alcohol, mouldy stored grain, unnecessary supplements, and untreated diabetes or obesity. See causes and risk factors for why each of these matters.